A potent beta-adrenoreceptor blocking drug: 4- (2-hydroxy-3-isopropylaminopropoxy) indole
Moore, G.E.; O'Donnell, S.R.
Journal of Pharmacy and Pharmacology 22(3): 180-188
1970
ISSN/ISBN: 0022-3573 PMID: 4399485 Document Number: 20321
Document emailed within 1 workday
Related Documents
1979: Adverse Drug Reactions Advisory Committee. Peyronie's disease. A complication in therapy with beta-adrenoreceptor blocking drugs? Medical Journal of Australia 2(8): 432Sillevis Smitt, J.H.; van Joost, T. 1981: Beta-adrenoreceptor blocking drugs and epicutaneous allergologic studies Nederlands Tijdschrift Voor Geneeskunde 125(1): 17-18
England, J.D. 1981: Beta adrenoreceptor-blocking drugs once daily in essential hypertension: a comparison of propranolol, pindolol and atenolol Australian and New Zealand Journal of Medicine 11(1): 35-40
Lutsky, B.N.; Millonig, R.C.; Wojnar, R.J.; Free, C.A.; Devlin, R.G.; Varma, R.K.; Karanewsky, D.S. 1986: Androstene-17-thioketals. 2nd communication: pharmacological profiles of tipredane and (11 beta, 17 alpha)-17-(ethylthio)-9 alpha-fluoro-17-[2-(fluoroethyl)thio]-11 beta-hydroxy-androsta-1,4-dien-3-one, structurally novel 20-thiasteroids possessing potent and selective topical antiinflammatory activity Arzneimittel-Forschung 36(12): 1787-1795
Buist, R.A.; Williams, L.R.; Cairncross, K.D. 1974: Pharmacology of sympathomimetic amines with beta-adrenoreceptor agonist and alpha-adrenoreceptor antagonist properties Archives Internationales de Pharmacodynamie et de Therapie 209(2): 227-236
Asada, H.; Nanjo, T.; Itoh, T.; Suzuki, H.; Kuriyama, H. 1982: Effects of 3,4-dihydro-8-(2-hydroxy-3-isopropylaminopropoxy)-3-nitroxy-2H-1-bezopyran (K-351) on smooth muscle cells and neuromuscular transmission in guinea-pig vascular tissues Journal of Pharmacology and Experimental Therapeutics 223(2): 560-572
Manna, F.; Bolasco, A.; Bizzarri, B.; Lena, R.; Chimenti, F.; Filippelli, A.; Palla, A.; Fontana, M. 1996: Synthesis and beta-adrenoreceptor blocking activity of [[3-(alkylamine)-2-hydroxypropyl]oximino]pyridines and O[3-(alkylamine)-2-hydroxypropyl]methylpyridine ketone oximes derivatives Farmaco 51(8-9): 579-587
Palatsi, R. 1976: A skin reaction to pindololum, a beta-blocking drug Annals of Clinical Research 8(4): 239-240
Bauer, G.E.; Michell, G. 1970: Oxprenolol: clinical experiences with a new beta-adrenergic blocking drug Medical Journal of Australia 1(4): 170-173
Chalmers, J.; Wing, L.; West, M.; Bune, A.; Johnston, C.; Jackson, B.; McGrath, B.; Mashford, M.L.; Heath, W.; Westwood, B. 1987: Felodipine compared to prazosin as additional therapy to a beta-blocking drug Journal of Cardiovascular Pharmacology 10(Suppl 10): S82-S84
Pyörälä, K.; Mattila, S.; Leirisalo, M.; Toivonen, S. 1976: The antihypertensive effect of a new beta-blocking drug timolol in combination with hydrochlorothiazide Duodecim; Laaketieteellinen Aikakauskirja 92(11): 588-596
Batlle, F.; Carreño, C.A.; Guetta, N.J.; Vassolo, E.; Bertolasi, C.A. 1970: Treatment of cardiac arrhythmias using a beta adrenergic receptor blocking drug Prensa Medica Argentina 57(38): 1801-1808
Broadbent, T.A.; Broadbent, H.S. 1998: 1. the chemistry and pharmacology of indole-3-carbinol (indole-3-methanol) and 3-(methoxymethyl)indole. [Part Ii Current Medicinal Chemistry 5(6): 469-491
Teotia, S.P.; Tripathi, T.K.; Bhaskaran, V.K.; Teotia, M.; Sharma, N.L. 1972: Urinary excretion of 5-hydroxy indole acetic acid (5-HIAA) in children with kwashiorkor Indian Pediatrics 9(8): 467-470
Jäättelä, A.; Pyöräiä, K. 1976: The antihypertensive effect of a new beta-adrenergic blocking drug metroprolol in combination with chlorthalidone Duodecim; Laaketieteellinen Aikakauskirja 92(11): 597-603
Cerasola, G.A.; Botta, R.M.; Riolo, A.; Amico, L.M. 1979: Efficacy of a new beta-blocking drug (atenolol, ICi 66082) in treating arterial hypertension Bollettino Della Societa Italiana di Cardiologia 24(5): 493-500
Pentel, P.R.; Salerno, D.M. 1990: Cardiac drug toxicity: digitalis glycosides and calcium-channel and beta-blocking agents Medical Journal of Australia 152(2): 88-94
Nakahara, H.; Nakazawa, M.; Tsukada, T.; Imai, S. 1985: Mechanism of the hypotensive effect of a new beta-adrenergic blocking drug, arotinolol (S-596) in anesthetized rabbits Archives Internationales de Pharmacodynamie et de Therapie 277(2): 253-263
Motolese, M. 1970: Factorial design in a balanced incomplete block in the evaluation of the minimal active dose of a beta-blocking drug Bollettino Chimico Farmaceutico 109(6): 363-368
De Ambroggi, L.; Perotta, G.M.; Satolli, R.; Lotto, A. 1977: Evaluation of the effects of a beta-blocking drug (moprolol) on hemodynamics and lesion potentials in acute myocardial infarct Bollettino Della Societa Italiana di Cardiologia 22(8): 1343-1351